West Branch Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
West Branch Capital's IBB Position: Q3 2026 in Review
West Branch Capital held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 114 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #185.
West Branch Capital first reported a position in IBB in Q2 2018 and has held it in 25 quarters since. The position peaked at $575K in Q2 2018. 1,026 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- West Branch Capital held 114 shares of iShares Biotechnology ETF worth $24K as of Q3 2026.
- West Branch Capital left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up 0.01% of West Branch Capital's portfolio in Q3 2026, its #185 holding.
- West Branch Capital first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 25 quarters since.
- West Branch Capital's iShares Biotechnology ETF position peaked at $575K in Q2 2018.
- 1,026 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on West Branch Capital's 13F filing for Q3 2026, filed 20 Oct 2026.